Goes 2015

Goes FS, McGrath J, Avramopoulos D, Warren ST, et al.  Genome-Wide Association Study of Schizophrenia in Ashkenazi Jews.  American Journal of Medical Genetics, Neuropsychiatric Genetics, Manuscript Accepted  2 July 2015.

Myrick 2015

Myrick L, Deng P-Y, Hashimoto H, Warren ST, et al.  Independent role for presynaptic FMRP revealed by an FMR1 missense mutation assocation with intellectual disability and seizures.  PNAS, VOL. 112, no. 4, 949-956, Jan. 27, 2015.


Alpatoc 2014

Alpatov R, Lesch BJ, Nakamoto-Kinoshita, M, Warren, ST, et al.  A Chromatin-Dependent Role of the Fragile X Mental Retardation Protein FMRP in the DNA Damage Response.  Cell 157, 869-881, May 8, 2014.

Chopra 2014

Chopra P, Papale LA, White A, Warren ST, et al.  Array-based assay detects genome-wide 5-mC and 5-hmC in the brains of humans, non-human primates, and mice.  BMC Genomics 2014, 15:131.

Mulle 2014

Mulle JG, Pulver AE, McGrath JA, Warren ST, et al.  Reciprocal Duplication of the Williams-Beuren Syndrome Deletion on Chromosome 7q11.23 Is Associated with Schizophrenia.  Biol Psychiatry 2014;75:371-377.

Myrick 2014

Myrick LK, Nakamoto-Kinoshita M, Lindor NM, Warren ST, et al.  Fragile X syndrome due to a missense mutation.  European Journal of Human Genetics (2014) 22, 1185-1189.

Myrick 2014b

Myrick LK, Hashimoto H, Cheng X, Warren STHuman FMRP contains an integral tandem Agenet (Tudor) and KH motif in the amino terminal domain.  Human Molecular Genetics, 2015, Vol.24, No.6, 1733-1740.

Satten 2014

Satten GA, Allen AS, Ikeda M, Mulle JG and Warren STRobust Regression Analysis of Copy Number Variation Data based on a Univariate Score. PLOS One, Feb. 2014, Vol.9, Issue 2.

Suhl 2014 Suhl JA, Chopra P, Anderson BR, Bassell GJ and Warren STAnalysis of FMRP mRNA target datasets reveals highly associated mRNAs mediated by G-quadruplex structures formed via clustered WGGA sequences.  Human Molecular Genetics, 2014, Vol. 23, No. 20, 5479-5491.
Zhu 2014 Zhu G, Li Y, Zhu F, Wang T, Warren ST, et al.  Coordination of Engineered Factors with TETI/2 Promotes Early-Stage Epigenetic Modification during Somatic Cell Reprogramming.  Stem Cell Reports, Vol. 2, 253-261, March 11, 2014.


Alisch RS, Wang T, Chopra P, Visootsak J, Conneely KN, Warren STGenome-wide analysis validates aberrant methylation in fragile X syndrome is specific to the FMR1 locus.  BMC Med Genet.  2013 Jan 29;14:18. doi: 10.1186/1471-2350-14-18.

Nelson DL, Orr HT, Warren STThe unstable repeats--three evolving faces of neurological disease.  Neuron. 2013 Mar 6:77(5):825-43. doi: 10.1016/j.neuron.2013.02.022. Review.

McDonald-McGinn DM, Fahiminiya S, Revil T, Nowakowska BA, Suhl J, Bailey A, Mlynarski E, Lynch DR, Yan AC, Bilaniuk LT, Sullivan KE, Warren ST, Emanuel BS, Vermeesch JR, Zackai EH, Jerome-Majewska LA.  Hemizygous mutations in SNAP29 unmask autosomal recessive conditions and contribute to atypical findings in patients with 22q11.2DS.  J Med Genet, 2013 Feb;50(2):80-90. doi: 10.1136/jmedgenet-2012-101320. Epub 2012 Dec 11.

Wang T, Wu H, Li Y, Szulwach KE, Lin L, Li X, Chen IP, Goldlust IS, Chamberlain SJ, Dodd A, Gong H, Ananiev G, Han JW, Yoon YS, Katharine Rudd M, Yu M, Song CX, He C, Chang Q, Warren ST, Jin P.  Subtelomeric hotspots of aberrant 5-hydroxymethylcytosine-mediated epigenetic modifications during reprogramming to pluripotency.  Nat Cell Biol. 2013 Jun;15(6):700-11. doi: 10.1038/ncb2748. Epub 2013 May 19.


Emanuel BS, Warren ST, Garber KB.  The human genome: a diamond in the rough.  Curr Opin Genet Dev. 2012 Jun;22(3):189-90. doi: 10.1016/j.gde.2012.04.005. Epub 2012 May 18. No abstract available.

Buxbaum JD, Daly MJ, Devlin B, Lehner T, Roeder K, State MW; Autism Sequencing Consortium.  The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders.  Neuron.2012 Dec 20;76(6):1052-6. doi: 10.1016/j.neuron.2012.12.008.
Mulle JG, Warren ST.  Genomic tics in tourette syndrome.  Biol Psychiatry. 2012 Mar 1;71(5):390-1.  doi: 10.1016/j.biopsych.2011.12.017. No abstract available.
Wang T, Bray SM, Warren STNew perspectives on the biology of fragile X syndrome. Curr Opin Genet Dev. 2012 Jun;22(3):256-63. doi: 10.1016/j.gde.2012.02.002. Epub 2012 Feb 28. Review.

Kenny EE, Pe'er I, Karban A, Ozelius L, Mitchell AA, Ng SM, Erazo M, Ostrer H, Abraham C, Abreu MT, Atzmon G, Barzilai N, Brant SR, Bressman S, Burns ER, Chowers Y, Clark LN, Darvasi A, Doheny D, Duerr RH, Eliakim R, Giladi N, Gregersen PK, Hakonarson H, Jones MR, Marder K, McGovern DP, Mulle J, Orr-Urtreger A, Proctor DD, Pulver A, Rotter JI, Silverberg MS, Ullman T, Warren ST, Waterman M, Zhang W, Bergman A, Mayer L, Katz S, Desnick RJ, Cho JH, Peter I.  A genome-wide scan of Ashkenazi Jewish Crohn's disease suggests novel susceptibility loci.  PLoS Genet. 2012:e1002559. doi: 10.1371/journal.pgen.1002559. Epub 2012 Mar 8.

Santoro MR, Bray SM, Warren STMolecular mechanisms of fragile X syndrome: a twenty-year perspective.  Annu Rev Pathol. 2012:7:219-45.doi: 10.1146/annurev-pathol-011811-132457. Epub 2011 Oct 10.

Henderson C, Wijetunge L, Kinoshita MN, Shumway M, Hammond RS, Postma FR, Brynczka C, Rush R, Thomas A, Paylor R, Warren ST, Vanderklish PW, Kind PC, Carpenter RL, Bear MF, Healy AM.  Reversal of disease-related pathologies in the fragile X mouse model by selective activation of GABA(B) receptors with arbaclofen.  Sci Transl Med. 2012 Sep 19;4(152):152ra128

Wang T, Pan Q, Lin L, Szulwach KE, Song CX, He C, Wu H, Warren ST, Jin P, Duan R, Li X.  Genome-wide DNA hydroxymethylation changes are associated with neurodevelopmental genes in the developing human cerebellum.  Hum Mol Genet. 2012 Dec 15;21(26):5500-10. doi: 10.1093/hmg/dds394. Epub 2012 Oct 5.


Muddashetty RS, Nalavadi VC, Gross C, Yao X, Xing L, Laur O, Warren ST, and Bassell GJ.  Reversible Inhibition of PSD-95 mRNA Translation by miR-125a, FMRP Phosphorylation, and mGluR Signaling.  Molecular Cell 42: 673-688 (June 2011).
Kaminsky EB, Kaul V, Paschall J, Church DM, Bunke B, Kunig D, Moreno-de-Luca D, Morneno-de-Luca A, Mulle JG, Warren ST, et al.  An evidence-based approach to establish the functional and clinical significance of copy number variants in intellectual and developmental disabilities.  Genetics in Medicine, Vol 13 (9): 777-784 (Sept 2011)
Giriajan S, Brkanac Z, Coe BP, Baker C, Vives L, Vu TH, Shafer N, Bernier R, Ferrero GB, Silengo M, Warren ST, Moreno CS, Fichera M, Romano C, Raskind WH, and Eichler EE.  Relative Burden of Large CNVs on a Range of Neurodevelopmental Phenotypes.  PLoS Genetics, Vol 7(11): 1-17 (Nov 2011)
Liu-Yesucevitz L, Bassell GJ, Gitler AD, Hart AC, Klann E, Richter JD, Warren ST, and Wolozin B.  Local RNA Translation at the Synapse and in Disease.  The Journal of Neuroscience, 31(45); 16086-16093. (Nov 2011)


Collins SC, Bray SM, Suhl JA, Cutler DJ, Coffee B, Zwick ME, and Warren ST.  Identification of Novel FMR1 Variants by Massively Parallel Sequencing in Developmentally Delayed Males.  Amer J of Medical Genetics Part A, 152A:2512-2520 (2010).
Jennifer Gladys Mulle, Anne F. Dodd, John A. McGrath, Paula S. Wolyniec, Adele A. Mitchell, Amol C. Shetty, Nara L. Sobreira, David Valle, M. Katharine Rudd, Glen Satten, Steve Warren, et al. Microdeletions of 3q29 Confer High Risk for Schizophrenia. The American Journal of Human Genetics, 87, 1-8 (2010).

Moreno-De-Luca D; SGENE Consortium, Mulle JG; Simons Simplex Collection Genetics Consortium, Kaminsky EB, Sanders SJ; GeneSTAR, Myers SM, Adam MP, Pakula AT, Eisenhauer NJ, Uhas K, Weik L, Guy L, Care ME, Morel CF, Boni C, Salbert BA, Chandrareddy A, Demmer LA, Chow EW, Surti U, Aradhya S, Pickering DL, Golden DM, Sanger WG, Aston E, Brothman AR, Gliem TJ, Thorland EC, Ackley T, Iyer R, Huang S, Barber JC, Crolla JA, Warren ST, Martin CL, Ledbetter DH.  Deletion 17q12 is a recurrent copy number variant that confers high risk of autism and schizophrenia.  Am J Hum Genet. 2010 Nov 12: 87(5):618-30. doi: 10.1016/j.ajhg.2010.10.004. Epub 2010 Nov 4, Erratum

Zoghbi HY and Warren ST.  Neurogenetics: Advancing the \"Next-Generation\" of Brain Research.  Neuron 68, 165-173 (2010).
Collins S C, Coffee B, Benke P J, Berry-Kravis E, Gilbert F, Oostra B, Halley D, Zwick ME, Cutler DJ and Warren ST.  Array-Based FMR1 Sequencing and Deletion Analysis in Patients with a Fragile X Syndrome-Like Phenotype.  PLoS ONE 5(3): e9476, doi:10.1371/journal.pone.0009476 (2010).
Mulle JG, Patel VC, Warren ST, Hegde MR, Cutler DJ, and Zwick ME.  Empirical Evaluation of Oligonucleotide Probe Selection for DNA Microarrays.  PLOS One Volume 5, Issue 3, e9921 (March 2010).
Gross C, Nakamoto M, Yao X, Chan C-B, Yim SY, Ye K, Warren ST, and Bassell GJ.  Excess Phosphoinositide 3-Kinase Subunit Synthesis and Activity as a Novel Therapeutic Target in Fragile X Syndrome.  The J of Neuroscience 30(32):10624-10638 (Aug 2010).
Moreno-de-Luca D, SGENE Consortium, Mulle JG, Simons Simplex Collection Genetics Consortium, Kaminsky EB, Sanders SJ, GeneSTAR, Myers SM, Adam MP, Pakula AT, Eisenhauer NJ, Uhas K, Weik L, Guy L, Care ME, Morel CE, Boni C, Salbert BA, Chandareddy A, Demmer LA, Chow EWC, Surti U, Aradhya S, Pickering DL, Golden DM, Sanger WG, Aston E, Brothman AR, Gliem TJ, Thorland EC, Ackley T, Iyer R, Huang S, Barber JC, Crolla JA, Warren ST, Martin CL and Ledbetter DH.  Deletion 17q12 is a Recurrent Copy Number Variant that Confers High Risk of Autism and Schizophrenia. The Amer J of Human Genetics 87, 618-630 (2010).
Bray SM, Mulle JG, Dodd AF, Pulver AE, Wooding S and Warren ST.  Signatures of founder effects, admixture, and selection in the Ashkenazi Jewish population.  PNAS vol. 107, no. 37 16222-16227 (2010).


Arlt MF, Mulle JG, Schaibley VM, Ragland RL, Durkin SG, Warren ST and Glover TW: Replication Stress Induces Genome-wide Copy Number Changes in Human Cells that Resemble Polymorphic and Pathogenic Variants.  American J of Human Genetics 84, 339-350 (2009).
Coffee B, Keith K, Albizua I, Malone T, Mowrey J, Sherman SL and Warren ST: Incidence of Fragile X Syndrome by Newborn Screening for Methylated FMR1 DNA. The American J of Human Genetics 85, 503-514. (2009)


Durkin SG, Ragland RL, Arlt MF, Mulle JG, Warren ST, and Glover TW: Replication stress induces tumor-like microdeletions in FHIT/FRA3B. PNAS vol. 105 no. 1, 246-251 (2008).
Bassell GJ and Warren ST: Fragile X Syndrome: Loss of Local mRNA Regulation Alters Synaptic Development and Function. Neuron, 60, 201-211(Oct. 2008).
Chang S, Bray SM,  Li Z, Zarnescu DC, He C, Jin P & Warren ST: Identification of small molecules rerscuing fragile X syndrome phenotypes in Drosophila. Nature Chemical Biology, Vol. 4, No. 4, 256-262 (2008).
Coffee B, Ikeda M, Budimirovic DB, Hjelm LN, Kaufmann WE and Warren ST: Mosaic FMR1 Deletion Causes Fragile X Syndrome and Can Lead to Molecular Misdiagnosis: A Case Report and Review of the Literature.  American J of Medical Genetics Part A 146A:1358-1367 (2008).
Garber KB, Visootsak J and Warren ST: Fragile X syndrome.  European J of Human Genetics 16, 666-672 (2008).
Narayanan U, Nalavadi V, Nakamoto M, Thomas G, Ceman S, Bassell GJ and Warren ST: S6K1 Phosphorylates and Regulates Fragile X Mental Retardation Protein (FMRP) with the Neuronal Protein Synthesis-dependent Mammalian Target of Rapamycin (mTOR) Signaling Cascade. J of Biological Chemistry, Vol 283 No. 27 (2008).
Weinshenker D and Warren ST: Fragile dopamine.  Nature, Vol 455, 607-608 (2008).


Warren, ST: 2006 ASHG Presidential Address: Our Society and the Scientist-Citizen. The American Journal of Human Genetics, Volume 81, 642-43(2007).
Friedman, MJ, Shah, AG, Fang, Z-H, Ward, E, Warren, ST, Li, S & Li, X-J: Polyglutamine domain modulates the TBP-TFIIB interaction: implications for its normal function and neurodegeneration; Nature Neuroscience; Vol 10, Number 12, 1519-27 (2007).
Nishimura, Y, Martin, CL, Lopez, AV, Spence, SJ, Alvarez-Retuerto, AI, Sigman, M, Steindler, C, Pellegrini, S, Schanen, NC, Warren, ST, and Geschwind, DH: Genome-wide expression profiling of lymphoblastoid cell lines distinguishes different forms of autism and reveals shared pathways. Human Molecular Genetics. 2--8. Vol. 16, No. 14, 1682-1698 (2007).
Jin, P, Duan, R, Qurashi, A, Qin, Y, Tian, D, Rosser, TC, Huijie, L, Feng, Y and Warren, ST: Pur α Binds to rCGG Repeats and Modulates Repeat-Mediated Neurodegeneration in a Drosophila Model of Fragile X Tremor/Ataxia Syndrome; Neuron, 55, 556-564 (2007).
Penagarikano O, Mulle JG, and Warren ST: The Pathophysiology of Fragile X Syndrome; Annual Rev. Genomics Hum. Genet., 8:109-29 (2007).
Narayanan, U, Nalavadi, V, Nakamoto, M, Pallas, DC, Ceman, S, Bassell, GJ and Warren, ST: FMRP Phosphorylation Reveals an Immediate-Early Signaling Pathway Triggered by Group I mGluR and Mediated by PP2A; The Journal of Neuroscience, 27(52):14349-14357 (2007).
Viel, KR, Machiah, DK, Warren, DM, Khachidze, M, Buil, A, Fernstrom, K, Souto, JC, Peralta, JM, Smith, T, Blangero, J, Porter, S, Warren, ST, Fontcuberta, J, Soria, JM, Flanders, D, Almasy, L and Howard, TE: A sequence variation scan of the coagulation factor VIII (FVIII) structural gene and associations with plasma FVIII activity levels. Blood, 109: 3713-3724 (2007).
Alisch RS, Jin P, Epstein M, Caspary T, and Warren ST: Argonaute2 Is Essential for Mammalian Gastrulation and Proper Mesoderm Formation; PLOS Genetics; Vol 3, Issue 12, e227 (2007).
Nakamoto, N, Nalavadi, V, Epstein, MP, Narayanan, U, Bassell, GJ and Warren, ST: Fragile X mental retardation protein deficiency leads to excessive mGluR5-dependent internalization of AMPA receptors; PNAS, Vol. 104, no. 39, pp 15537-15542 (2007).


Coffee, B,  Muralidharan, K,  Highsmith Jr., WE, Lapunzina, P and Warren, ST: Molecular diagnosis of Beckwith-Wiedemann Syndrome using quantitative methylation-sensitive polymerase chain reaction; Genetics in Medicine, Vol 8 - No.10 (2006).
Garber, K, Smith, KT, Reines, D and Warren, ST: Transcription, translation and fragile X syndrome; Current Opinion in Genetics & Development, 16:270-275 (2006).


Visootsak, J, Warren, ST, Anido, A, and Graham, JM: Fragile X syndrome: an update and review for the primary pediatrician. Clinical Pediatrics 44:371-381 (2005).
Zarnescu, DC, Jin, P, Nakamoto, M, Dockendorff, TC, Feng, Y, Jongens, TA, Warren, ST and Moses, K: Fragile X protein functions with lgl and the par complex in flies and mice. Developmental Cell 8:43-52 (2005).
Khachidze, M,  Buil, A, Viel, KR, Porter, S,  Warren, D, Machiah, DK, Soria, JM,  Souto, JC,  Ameri, A,  Lathrop, M, Blangero, J,  Fontcuberta, J,  Warren, ST, Almasy, L and Howard, TE: Genetic determinants of normal variation in coagulation factor (F) IX levels: genome-wide scan and examination of the FIX structural gene; Journal of Thrombotis and Haemostasis, 4: 1537-1545.
Nakamoto, M, Jin, P, O\'Donnell, WT and Warren, ST: Physiological identification of human transcripts translationally regulated by specific microRNAs. Human Molecular Genetics 14:3813-3821 (2005).
Zarnescu, DC, Warren, ST and Jin, P: Come FLY with us: Towards understanding fragile X syndrome. Genes, Brain and Behavior 4:385-392 (2005).


Jin, P, Alisch, RS, and Warren, ST: RNA and microRNAs in fragile X mental retardation. Nature Cell Biology 11:1048-1053 (2004).
Kaytor, MD, Iber, JC, Wilkinson KD and Warren, ST: Modulating huntingtin half-life alters polyglutamine-dependent aggregate formation and cell toxicity. Journal of Neurochemistry 89:962-973 (2004).
Lu, R, Wang, H, Ku, L, Liang, Z, O’Donnell, WT. Li, W, Warren, ST and Feng, Y: Developmentally aberrant MAP1B translation and microtubule dynamics in fragile X neurons. Proceedings of the National Academy of Sciences, USA 101: 15201-15206 (2004).
 Jin, P, Zarnescu, DC, Ceman, S, Nakamoto, M, Mowrey, J, Jongens, TA, Nelson, DL, Moses, K and Warren, ST: Biochemical and genetics interaction between fragile X protein and microRNA pathway. Nature Neuroscience 7:113-117 (2004).
Bear, MF, Huber, KM and Warren, ST: The mGluR theory of fragile X mental retardation.  Trends in Neurosciences 27:370-377 (2004).
Darnell, JC, Warren, ST and Darnell, RB: The fragile X mental retardation protein, FMRP, recognizes G-quartets. Mental Retardation and Developmental Disabilities Research Reviews 10:49-52 (2004).


Jin, P and Warren, ST:  New insights into fragile X syndrome: from molecules to neurobehaviours.  Trends in Biochemical Sciences 28:152-158 (2003).
Ceman, S, O’Donnell, WT, Reed, M, Patton, S, Pohl, J and Warren, ST: Phosphorylation regulates translation state of FMRP-associated polyribosomes. Human Molecular Genetics 12:3295-3305 (2003).
Jin, P, Zarnescu, DC, Zhang, F, Pearson CE, Lucchesi, JC, Moses, K, and Warren, ST:  RNA-mediated neurodegeneration caused by the fragile X premutation in Drosophila. Neuron 39:739-747 (2003).


O’Donnell, WT and Warren, ST: A decade of molecular studies of fragile X syndrome. Annual Review of Neuroscience 25:315-338 (2002).
D’Agata, V, Warren, ST, Zhao, W, Torre, E, Alkon, D and Cavallaro, S: Gene expression profiles in a transgenic animal model of fragile X syndrome. Neurobiology of Disease 10:211-218 (2002).
Tarleton, J, Kenneson, A, Taylor, A, Crandall, K, Fletcher, R, Casey, R, Hart, S, Hatton, D, Bailey, D, Fisch, D, and Warren, ST: A single base alteration in the CGG repeat region of FMR1: Possible effects on gene expression and phenotype. Journal of Medical Genetics 39:196-200 (2002).
Coffee, B, Zhang, F, Ceman, S, Warren,ST and Reines, D: Epigenetic histone modifications depict an aberrantly heterochromatized FMR1 gene in fragile X syndrome. American Journal of Human Genetics 71:923-932 (2002).
Huber, KM, Gallagher, S, Warren, ST and Bear, MF: Altered synaptic plasticity in a mouse model of fragile-X mental retardation. Proceedings of the National Academy of Sciences, USA 99:7746-7750 (2002).


Li, Z, Zhang, Y,  Ku, L, Wilkinson, KD, Warren, ST and Feng, Y:   Translational Inhibition by the Fragile X Mental Retardation Protein. Nucleic Acids Research.29:2276-2283 (2001).
Kenneson, A and Warren, ST: The female and the fragile X reviewed. In: Adashi, E. (Ed.) Seminars in Reproductive Medicine 19:159-165 (2001).
Brown, V, Jin, P, Ceman, S, Darnell, JC, O’Donnell, WT, Tenenbaum, SA, Jin, X, Feng, Y, Wilkinson, KD, Keene, JD, Darenell, RB and Warren, ST: Microarray identification of FMRP-associated brain mRNAs and altered mRNA translational profiles in fragile X syndrome. Cell 107:477-487 (2001).
Kenneson, A, Zhang, F, Hagedorn, CH and Warren, ST: Reduced FMRP and increased FMR1 transcription is proportionally associated with CGG-repeat number in intermediate-length and premutation carriers. Human Molecular Genetics, 10:1449-1459 (2001).
Darnell, JC, Jensen, KB, Brown, V, Jin, P, Warren, ST and Darnell, RB: Fragile X mental retardation protein targets G-quartets mRNAs important for neuronal function. Cell 107:489-499 (2001).


Ceman, S, Nelson, R and Warren, ST: Identification of mouse YB1/p50 as a component of the FMRP-associated mRNP. Biochemical and Biophysical Research Communications 279:904-908 (2000).
Conway, KE, McConnell, BB, Bowring, CE, Donald, CD, Warren, ST and Vertino, PM:TMS1, a novel proapoptotic CARD protein, is a target of methylation-induced gene silencing in human breast cancers. Cancer Research 60:6236-6242 (2000).
Crawford, DC, Zhang, F, Wilson, B, Warren, ST and Sherman, SL: Fragile X CGG repeat structure among African-Americans: Identification of a novel factor responsible for repeat instability. Human Molecular Genetics 9:1759-1769 (2000).
Jin, P and Warren, ST: Understanding the molecular basis of fragile X syndrome. Human Molecular Genetics 9:901-908 (2000).
Tsui, S, Dai, T, Warren, ST and Yen, P: Association of the mouse infertility factor DAZL1 with actively translating polyribosomes. Biology of Reproduction 62:1655-1660 (2000).
Peier, AM, McIlwain, KL, Kenneson, A, Warren, ST, Paylor, R and Nelson, DL: (Over)correction of the FMR1 deficiency with YAC transgenics: Behavioral and physical features. Human Molecular Genetics 9:1145-1159 (2000).
Dongsheng, D, Boekhoudt, G, Zhou, F, Morris, A, Philipson, S, Warren, ST and Boss, JM: Sp1 binding is critical for promoter assembly and activation of the MCP-1 gene. Journal of Biological Chemistry 275:1708-1714 (2000).
Fryns, J-P, Borghgraef, M, Brown, WT, Chelly, J, Fisch, GS, Hamel, B, Hanauer, A, Lacombe, D, Luo, L, MacPherson, JN, Mandel, J-L, Moraine, C, Mulley, J, Nelson, D, Oostra, B, Partington, M, Ramakers, GJA, Roper, H-H, Rousseau, F, Schwartz, C, Steinbach, P, Stoll, C, Tranebjaerg, L, Turner, G, Van Bokhoven, HV, Vianna-Morgante, A, Villard, L and Warren, ST: Conference report: 9th international workshop on fragile X syndrome and X-linked mental retardation. American Journal of Medical Genetics 94:345-360 (2000).
Warren, ST: A new millennium and a new editor. American Journal of Human Genetics 66:3-5 (2000).
Crawford, DC, Schwartz, CE, Meadows, KL, Newman, JL, Taft, LF, Gunter, C, Bailey, DB, Brown, WT, Carpender, NJ, Howard-Peebles, P, Mazzocco, MM, Monaghan, KG, Nolin, SL, Reiss, AL, Roberson, J, Rohlfs, EM, Taylor, AK, Warren, ST and Sherman, SL: Survey of the fragile X syndrome CGG repeat and STR- and SNP- haplotypes in an African-American population. American Journal of Human Genetics 66:480-493 (2000).


Paradee, W, Melikian, HE, Rasmussen, DL, Kenneson, A, Conn, PJ and Warren, ST: Fragile X mouse: Evidence suggesting deficient amygdala function and subtle hippocampal deficits. Neuroscience 94:185-192 (1999).
Kaytor, MD and Warren, ST: Aberrant protein deposition and neurological disease. Journal of Biological Chemistry 274:37507-37510 (1999).
Ceman, S, Brown, V and Warren, ST: Isolation of an FMRP-associated mRNP and the identification of nucleolin and the fragile X-related proteins as components of the complex. Molecular and Cellular Biology 19:7925-7932 (1999).
Zacharias, AS, Wagener, ME, Warren, ST and Hopkins, LC: Emery-Dreifuss muscular dystrophy. Seminars in Neurology 19:67-79 (1999).
Coffee, B, Zhang, F, Warren, ST and Reines, D: Acetylated histones are associated with the FMR1 gene in normal but not fragile X syndrome cells. Nature Genetics 22:98-101 (1999).


Chou, H-H, Takematsu, H, Diaz, S, Iber, J, Nickerson, E, Wright, K, Muchmore, EA, Nelson, D, Warren, ST and Varki, A: A mutation in human CMP-sialic acid hydrolase occurred after Homo-Pan divergence. Proceedings of the National Academy of Sciences, USA 95:11751-11756 (1998).
Brown, V, Small, K, Lakkis, L, Feng, Y, Gunter, C, Wilkinson, KD and Warren, ST: Purified recombinant Fmrp exhibits selective RNA-binding as an intrinsic property of the fragile X mental retardation protein. Journal of Biological Chemistry 273:15521-15527 (1998).
Small, K and Warren, ST: Complete emerin deletions, resulting in Emery-Dreifuss muscular dystrophy, occurring on either Xq28 inversion backgrounds. Human Molecular Genetics 7:135-140 (1998).
Gunter, C, Paradee, W, Crawford, DC, Meadows, KA, Newman, J, Kunst, CB, Nelson, DL, Schwartz, C, Murray, A, Macpherson, JN, Sherman, SL and Warren, ST: Reexamination of factors associated with expansion of CGG repeats using a single nucleotide polymorphism of FMR1. Human Molecular Genetics 7:1935-1946 (1998). cover illustration.


Warren, ST: Polyalanine expansion in synpolydactaly might result from unequal crossing-over of HOXD13. Science 275:408-409 (1997).
Kenneson, A, Cramer, DW and Warren, ST: Fragile X premutations are not a major cause of early menopause. American Journal of Human Genetics 61:1362-1369 (1997).
Warren, ST: Trinucleotide repetition and fragile X syndrome. Hospital Practice 32:73 - 98 (1997). cover illustration.
Feng, Y, Gutekunst, C-A, Eberhart, DE, Yi, H, Warren, ST and Hersch, SM: Fragile X mental retardation protein: Nucleocytoplasmic shuttling and association with somatodentritic ribosomes. Journal of Neuroscience 17:1539-1547 (1997).
Feng, Y, Absher, D, Eberhart, DE, Brown, V, Malter, HE and Warren, ST: FMRP associates with polyribosomes as an mRNP and the I304N mutation of severe fragile X syndrome abolishes this association. Molecular Cell 1:109-118 (1997).
Malter, H, Iber, JC, Willemsen, R, de Graaff, E, Tarleton, JC, Leisti, J, Warren, ST and Oostra, BA: Characterization of the full fragile X syndrome mutation in fetal gametes. Nature Genetics 15:165-169 (1997).
Small, K, Wagener, M and Warren, ST: Isolation and characterization of the complete mouse emerin gene. Mammalian Genome 8:337-341 (1997).
Small, K, Iber, J and Warren, ST: Emerin deletion reveals a common X-chromosome nversion mediated by inverted repeats. Nature Genetics 16:96-99 (1997).
Kunst, CB, Leeflang, EP, Iber, JC, Arnheim, N and Warren, ST: The effect of FMR1 CGG repeat interruptions on mutation frequency as measured by sperm typing. Journal of Medical Genetics 34:627-631 (1997).
Losekoot, M, Hoogendoorn, E, Olmar, R, Jansen, CCAM, Oosterwolk, JC, van den Ouweland, AMW, Halley, DJJ, Warren , ST, Willemsen, R, Oostra, BA and Bakker, E: Prenatal diagnosis for the fragile X syndrome: Loss of mutation owing to a double recombinant or gene conversion event at the FMR1 locus. Journal of Medical Genetics 34:924-926 (1997).
Eberhart, DE and Warren, ST: The molecular basis of fragile X syndrome. Cold Spring Harbor Symposium on Quantitative Biology: Function and Dysfunction in the Nervous System. 61:679-687 (1997).


Price, DK, Zhang, F, Ashley, CT and Warren, ST: The chicken FMR1 gene is highly conserved containing a CTT 5\' untranslated repeat and encodes an RNA-binding protein. Genomics 31:3-12 (1996).
Eberhart, DE and Warren, ST: Nuclease sensitivity of permeabilized cells confirms altered chromatin formation at the fragile X locus. Somatic Cell and Molecular Genetics 22:435-441 (1996).
Warren, ST: The expanding world of trinucleotide repeats. Science 271:1374-1375 (1996).
DiMarco, SP, Glover, TW, Miller, DE, Reines, D and Warren, ST: Transcription elongation factor SII (TCEA) maps to human chromosome 3p22-p21.3. Genomics 36:185-188 (1996).
Kunst, CB, Zerylnick, C, Karickhoff, L, Eichler, E, Bullard, J, Chalifoux, M, Holden, JJA, Torroni, A, Nelson, DL and Warren, ST: FMR1 in global populations. American Journal of Human Genetics 58:513-522 (1996).
Lachiewicz, AM, Spiridigliozzi, GA, McConkie-Rosell, A, Burgess, D, Feng, Y, Warren, ST and Tarleton, J: A fragile X male with a broad smear on Southern blot analysis representing 100 to 500 CGG repeats and no methylation of the Eag I site of the FMR1 gene. American Journal of Medical Genetics 64:278-282 (1996).
Eberhart, DE, Malter, HA, Feng, Y and Warren, ST: FMRP is a ribonucleoprotein containing both nuclear localization and export signals. Human Molecular Genetics 5:1083-1092 (1996). cover illustration.


 Eichler, EE, Kunst, CB, Lugenbeel, KA, Ryder, OA, Davison, D, Warren, ST and Nelson, DL: Evolution of the cryptic FMR1 CGG repeat. Nature Genetics 11:301-307 (1995).
Small, K and Warren, ST: Analysis of FMRP, the protein deficient in fragile X syndrome. Mental Retardation and Developmental Disabilities Research Reviews 1:245-250 (1995).
Andersson, B, Lu, F, Muzny, DM, Warren, ST and Gibbs, RA: Complete sequence of a 38.5-kb human cosmid insert containing the polymorphic marker DXS455 from Xq28. DNA Sequence 5:219-223 (1995).
Ashley, CT and Warren, ST: Trinucleotide repeat expansion and human disease. Annual Review of Genetics 29:703-728 (1995).
Bione, S, Small, K, Aksmanovic, VMA, Ciccodicola, A, Merlini, L, Morandi, L, Kress, W, Yates, JRW, Warren, ST and Toniolo, D: Identification of new mutations in the Emery Dreifuss dystrophy gene and evidence for genetic heterogeneity of the disease. Human Molecular Genetics 4:1859-1864 (1995).
Warren, ST and Ashley, CT: Triplet repeat expansion mutations: The example of fragile X syndrome. Annual Review of Neuroscience 18:77-99 (1995).
Kirchgessner, CU, Warren, ST and Willard, HL: X inactivation of the FMR1 fragile X mental retardation gene. Journal of Medical Genetics 32:925-929 (1995).
Feng, Y, Zhang, F, Lokey, LK, Chastain, JL, Lakkis, L, Eberhart, D and Warren, ST: Translational suppression by trinucleotide repeat expansion at FMR1. Science 268:731-734 (1995).
Litt, M, Kramer, P, Kort, E, Fain, P, Cox, S, Root, D, White, R, Weissenbach, J, Donis-Keller, H, Gatti, R, Weber, J, Nakamura, Y, Julier, C, Hayashi, K, Spurr, N, Dean, M, Mandel, J, Kidd, K, Kruse, T, Retief, A, Bale, A, Meo, T, Vergnaud, G, Warren, ST and Willard, HF: The CEPH consortium linkage map of human chromosome 11. Genomics 27:101-112 (1995).
Feng, Y, Lakkis, L, Devys D and Warren, ST: Quantitative comparison of FMR1 gene expression in normal and premutation alleles. American Journal of Human Genetics 56:106-113 (1995).
Gregor, P, Nash, SR, Caron, MG, Seldin, MF and Warren, ST: Assignment of the creatine transporter gene to human chromosome Xq28 telomeric to G6PD. Genomics 25:332-333 (1995).
Zerylnick, C, Torroni, A, Sherman, SL and Warren, ST: Normal variation at the myotonic dystrophy locus in global human populations. American Journal of Human Genetics 56:123-130 (1995).


Malter, HE, Tucker, MJ and Warren, ST: Fragile X syndrome and trinucleotide repeat expansion mutations: New challenges for genetic analysis and diagnosis. Assisted Reproduction Review 4:67-73 (1994).
Kunst CB and Warren, ST: Cryptic and polar variation of the fragile X repeat could result in predisposing normal alleles. Cell 77:853-861 (1994).
Riggins, GJ, Zhang, F and Warren, ST: Lack of imprinting of BCR. Nature Genetics 6:226 (1994).

Warren, ST and Nelson, DL: Advances in molecular analysis of fragile X syndrome. Journal of the American Medical Association 271:536-542 (1994).

         • Japanese translation of the above article in: Advances in Research on Autism and Developmental Disorders, (R. Takagi, M. Rutter, E. Schopler, Eds.) Volume 2, pp. 124-135 (1998).

Riggins, GJ, Sherman, SL, Philips, CN, Stock, W, Westbrook, CA and Warren, ST: CGG-repeat polymorphism of the BCR gene rules out predisposing alleles leading to the Philadelphia chromosome. Genes, Chromosomes, and Cancer 9:141-144 (1994).
Van den Ouweland, AMW, Deelen, WH, Kunst, CB, Uzielli, M-L G, Nelson, DL, Warren, ST, Oostra, BA and Halley, DJJ: Loss of mutation at the FMR1 locus through multiple exchanges between maternal X chromosomes. Human Molecular Genetics 3:1823-1827 (1994).


Hornstra, IK, Nelson, DL, Warren, ST and Yang, TP: High resolution methylation analysis of the FMR1 gene trinucleotide repeat region in fragile X syndrome. Human Molecular Genetics 2:1659-1665 (1993).
Ashley, CT, Wilkinson, KD, Reines, D and Warren, ST: FMR1 protein: Conserved RNP family domains and selective RNA binding. Science 262:563-566 (1993).
Warren, ST and Nelson, DL: Trinucleotide repeat expansions in neurological disease.  Current Opinion in Neurobiology 3:752-759 (1993).
Gorlin, JB, Henske, E, Warren, ST, Kunst, CB, D\'Urso, M, Palmieri, G, Hartwig, JH, Bruns, G and Kwiatkowski, DJ: Actin-binding protein (ABP-280) filamin gene (FLN) maps telomeric to the color vision locus (R/GCP) and centromeric to G6PD in Xq28. Genomics 17:496-497 (1993).
Riggins, GJ, Lokey, LK and Warren, ST: CGG repeat polymorphism at the c-Ha-ras oncogene locus. Human Molecular Genetics. 1:775 (1993).
Hinds, HL, Ashley, CT, Sutcliffe, JS, Nelson, DL, Warren, ST, Housman, DE and Schalling, M: Tissue specific expression of FMR-1 provides evidence for a functional role in fragile X syndrome. Nature Genetics 3:36-43 (1993).
Nelson, DL and Warren, ST: Trinucleotide repeat instability: When and where? Nature Genetics 4:107-108 (1993).
Ashley, CT, Sutcliffe, JS, Kunst, CB, Leiner, HA, Eichler, EE, Nelson, DL and Warren, ST: Human and murine FMR-1: alternative splicing and translational initiation downstream of the CGG-repeat. Nature Genetics 4:244-251 (1993).
Kaneko, K, Warren, ST, Miyatake, T and Tsuji, S: Isolation of 353 Not I-linking clones and 62 DNA markers (DXS607-DXS668) from human chromosome Xq24-qter. Cytogenetics and Cell Genetics 64:5-8 (1993).
Warren, ST: Advances in human molecular genetics influence clinical genetic practice. ;l 6:34-36 (1992).
Smits, APT, Dreesen, JCFM, Post, JG, Smeets, DFCM, Die-Smulders, C, Spaans-van der Bijl, T, Govaerts, LCP, Warren, ST, Oostra, BA and van Oost, BA: The fragile X syndrome: No evidence for any recent mutations. Journal of Medical Genetics 30: 94-96 (1993).


Riggins, GJ, Lokey, LK, Chastain, JL, Leiner, HA, Sherman, SL, Wilkinson, KD and Warren, ST: Human genes containing polymorphic trinucleotide repeats. Nature Genetics 2:186-191 (1992).
Warren, ST: Mapping the vasopressin V2 receptor gene near nephrogenic diabetes insipidus. Dysmorphology and Clinical Genetics 6:203-205 (1992).
Sutcliffe, JS, Zhang, F, Nelson, DL, Caskey, CT and Warren, ST: PCR amplification and analysis of yeast artificial chromosomes. Genomics 13:1303-1306 (1992).
Van den Ouweland, Knoop, MT, Knoers, VVAM, Markslag, PWB, Rocchi, M. Warren, ST, Mandel, JL, Ropers, HH, Fahrenholz, F, Monnens, LAH and van Oost, BA: Colocalization of the gene for nephrogenic diabetes insipidus and the vasopressin type-2 receptor gene in the Xq28 region. Genomics 13:1350-1352 (1992).
Warren, ST: Advances in human molecular genetics influence clinical genetic practice. Dysmorphology and Clinical Genetics 6:34-36 (1992).
Consalez, GG, Stayton, CL, Freimer, NB, Goonewardena, Brown, WT, Gilliam, TC and Warren, ST: Isolation and characterization of a highly polymorphic human locus (DXS 455) in proximal Xq28. Genomics 12:710-714 (1992).
Verkerk, AJMH, de Vries, BBA, Niermeijer, MF, Nelson, DL, Warren, ST, Majoor-Krakauer, DF, Halley, DJJ and Oostra, BA: An intragenic probe used for diagnostics in fragile X families. American Journal of Medical Genetics 43:192-196 (1992).
Riggins, GJ, Sherman, SL, Oostra, BA, Sutcliffe, JS, Feitell, D, Nelson, DL, van Oost, BA, Smits, APT, Ramos, FJ, Pfender, E, Kuhl, D, Caskey, CT and Warren, ST: Characterization of a highly polymorphic dinucleotide repeat 150 kb proximal to the fragile X site. American Journal of Medical Genetics 43:237-243 (1992).
Traupe, H, van den Ouweland, AMW, van Oost, BA, Vogel, W, Vetter, U, Warren, ST, Rocchi, M, Darlison, MG and Roppers, HH: Fine mapping of the human biglycan (BGN) gene within the Xq28 region employing a hybrid cell panel. Genomics 13:481-483 (1992).
Willems, PJ, Vits, L, Raeymaekers, P, Beuten, J, Beuten, J, Coucke, P, Holden, JJA, Van Broeckhoven, CV, Warren, ST, Sagi, M, Robinson, D, Dennis, N, Friedman, J, Magnay, D, Lyonnet, S, White, BN, Wittwer, BH, Aylsworth, AS and Reicke, S: Further localization of X-linked hydrocephalus in the chromosomal region Xq28. American Journal of Human Genetics 51:307-315 (1992).
Sutcliffe, JS, Nelson, DL, Zhang, F, Pieretti, M, Caskey, CT, Saxe, D and Warren, ST: DNA methylation represses FMR-1 transcription in fragile X syndrome. Human Molecular Genetics 1:397-400 (1992).


Hirst, MC, Roche, A, Flint, TJ, MacKinnin, R, Bassett, JHD, Nakahori, Y, Watson, JEV, Bell, MV, Patterson, MN, Boyd, Y, Thomas, N, Knight, SJL, Warren, ST, Hors-Cayla, M, Schmidt, M, Sutherland, GR and Davies, KE: Linear order of new and established DNA markers around the fragile site at Xq27.3. Genomics 10:243-249 (1991).
Kremer, EJ, Pritchard, M, Lynch, M, Yu, S, Holman, K, Baker, E, Warren, ST, Schlessinger, D, Sutherland, GR and Richards, RI: Mapping of DNA instability at the fragile X to a trinucleotide repeat sequence p(CCG)n. Science 252:1711-1714 (1991).
Dietrich, A, Kioschis, P, Monaco, AP, Gross, B, Korn, B, Williams, SV, Sheer, D, Heitz, D, Oberle, I, Toniolo, D, Warren, ST, Lehrach, H and Poustka, A: Molecular cloning and analysis of the fragile X region in man. Nucleic Acids Research 19:2567-2572 (1991).
Poustka, A, Dietrich, A, Langenstein, G, Toniolo, D, Warren, ST and Lehrach, H: Physical map of human Xq27-qter: Localizing the region of the fragile X mutation. Proceedings of the National Academy of Sciences, USA 88:8302-8306 (1991).
Verkerk, AJMH, Pieretti, M, Sutcliffe, JS, Fu, Y-H, Kuhl, DPA, Pizzuti, A, Reiner, O, Richards, S, Victoria, MF, Zhang, F, Eussen, BE, van Ommen, GLB, Blonden, LAJ, Riggins, GJ, Chastain, JL, Kunst, CB, Gakljaard, H, Caskey, CT, Nelson, DL, Oostra, BA and Warren, ST: Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell 65:905-914 (1991).
Consalez, G., Thomas, NST, Stayton, C, Knight, SJL, Johnson, M, Hopkins LC, Harper, PS, Elsas, LJ and Warren, ST: Assignment of Emery-Dreifuss muscular dystrophy to the distal region of Xq28: The results of a collaborative study. American Journal of Human Genetics 48:468-480 (1991).
Fu YH, Kuhl DP, Pizzuti A, Pieretti M, Sutcliffe JS, Richards S, Verkerk AJ, Holden JJA, Fenwick RG Jr, Warren ST, Oostra BA, Nelson DL, and Caskey CT: Variation of the CGG Repeat at the Fragile X Site Results in Genetic Instability: Resolution of the Sherman Paradox.  Cell, Vol 67, Dec. 20, 1991, 1047-1058.
Rousseau, F, Vincent, A, Toniolo, D, Heitz, D, Warren, ST, Suthers, GK, Goodfellow, P, Mandel, JL and Oberle, I: Four chromosomal breakpoints and four new probes mark out a 10 cM region encompassing the FRAXA locus. American Journal of Human Genetics 48:108-116 (1991).
Yu, S, Kremer, E, Pritchard, M, Lynch, M, Nancarrow, J, Baker, E, Holman, K, Mulley, JC, Warren, ST, Schlessinger, D, Sutherland, GR and Richards, RI: The fragile X genotype is characterized by an unstable region of DNA. Science 252:1179-1181 (1991).
Pieretti, M, Fu, Y-H, Warren, ST, Zhang, F, Oostra, BA, Caskey, CT and Nelson, DL: Absence of expression of the FMR-1 gene in fragile X syndrome. Cell 66:817-822 (1991).


Warren, ST, Knight, SJL, Peters, JF, Stayton, CL, Consalez, GG and Zhang, F: Isolation of the human chromosomal band Xq28 within somatic cell hybrids by fragile X site breakage. Proceedings of the National Academy of Sciences, USA 87:3856-3860 (1990). 
Ledbetter, SA, Nelson, DL, Warren, ST, and Ledbetter, DH: Rapid isolation of DNA probes within specific chromosome regions by interspersed repetitive sequence polymerase chain reaction. Genomics 6:475-481 (1990).


El-Fouly, MH, Trosko, JE, Chang, CC and Warren, ST: Potential role of the human H-ras oncogene in the inhibition of gap junctional intercellular communication. Molecular Carcinogenesis 2:131-135 (1989).


Warren, ST, Zhang, F, Sutcliffe, JS and Peters, JF: Strategy for molecular cloning of the fragile X site. American Journal of Medical Genetics 30:613-623 (1988).
Warren, ST: Fragile X syndrome: A hypothesis regarding the molecular mechanism of the phenotype. American Journal of Medical Genetics 30:681-688 (1988).
Priest, JH, Blackston, RD, Pearse, LA and Warren, ST: Molecular evidence for true isochromosomes of 21q. Human Genetics 81:1-3 (1988).


Warren, ST, Zhang, F, Licameli. GR and Peters, JF: The fragile X site in somatic cell hybrids: An approach for molecular cloning of fragile sites. Science 237:420-423 (1987). cover illustration.


Smith, GF and Warren, ST: The biology of Down syndrome. Annals of the New York Academy of Science 450: 1-9 (1985).
Warren, ST, Glover, TW, Davidson, RL and Jagadeeswaran, P: Linkage and recombination between fragile X-linked mental retardation and the factor IX gene. Human Genetics 69: 44-46 (1985).


Warren, ST and Davidson, RL: Expression of the fragile X chromosome in human rodent somatic cell hybrids. Somatic Cell & Molecular Genetics 10: 409-413 (1984).
Jagadeeswaran, P, Lavelle, D, Kaul, R, Mohandas, T and Warren, ST: Isolation and characterization of human factor IX cDNA: Identification of Taq I polymorphism and regional assignment. Somatic Cell & Molecular Genetics 10: 465-474 (1984).


Trosko, JE, Yotti, LP, Warren, ST, Tsushimoto, G and Chang, CC: Inhibition of cell-cell communication by tumor promoters. Carcinogenesis: A Comprehensive Survey 7:565-585 (1982).
Warren, ST, Doolittle, DJ, Goodman, JI, Chang, CC and Trosko, JE: Evaluation of the carcinogenic potential of 2,4-dinitrofluorobenzene and its implications regarding mutagenicity testing. Carcinogenesis 3: 139-145 (1982).


Chang, CC, Boezi, JA, Warren, ST, Sabourin, CLK, Liu, PK, Glatzer, L and Trosko, JE: Isolation and characterization of a UV-sensitive, hypermutable, aphidicolin-resistant Chinese hamster cell line. Somatic Cell Genetics 7:235-253 (1981).
Warren, ST, Schultz, RA, Wade, MH, Chang, CC and Trosko, JE: Elevated spontaneous mutation rate in Bloom syndrome fibroblasts. Proceedings of the National Academy of Sciences, USA 78:3133-3137 (1981).
Warren, ST: Allelism in human oculocutaneous albinism. American Journal of Human Genetics 33: 479 (1981) Letter.
Scott-Emaukpor, AB, Warren, ST, Kapur, S, Quichon, EB and Higgins, JV: Familial occurrence of congenital pulmonary lymphangiectasis: Case report and genetic implications. American Journal of Diseases of Children 135: 532-534 (1981).
Warren, ST, Yotti, LP, Moskal, JR, Chang, CC and Trosko, JE: Metabolic cooperation in CHO and V79 cells following treatment with a tumor promoter. Experimental Cell Research 131: 427-430 (1981).


Toriello, HV, Warren, ST and Lindstrom, JA: Possible X-linked anencephaly and spina bifida - Report of a kindred. American Journal of Medical Genetics 6:119-121 (1980).


Chang, CC, Trosko, JE and Warren, ST: In vitro assay for tumor promoters and anti-promoters. Journal of Environmental & Pathological Toxicology 2:43-64 (1978).


Scott-Emuakpor, AB, Uviovo, JE and Warren, ST: Genetic variation in Nigeria: I. The genetics of phenylthiourea tasting ability. Human Heredity 25:360-369 (1975).